DOMH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.74%

Insider Buying (Last 12 Months): $305,707.81

Insider Selling (Last 12 Months): $0.00

Dominari Insider Trading History Chart

Dominari Share Price & Price History

^$1.71

+0.30 (1.20%)

As of 10/30/2024 01:00 AM ET

Days: 30 | 90 | 365

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Dominari Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/29/2024	Anthony Hayes	CEO	Buy	1,158	$2.25	$2,605.50	219,664
5/29/2024	Kyle Michael Wool	President	Buy	5,000	$2.20	$11,000.00	27,750
4/8/2024	Kyle Michael Wool	President	Buy	8,500	$2.99	$25,415.00	22,750
4/4/2024	Anthony Hayes	CEO	Buy	3,944	$2.62	$10,333.28	102,748
4/4/2024	Kyle Michael Wool	President	Buy	19,000	$2.87	$54,530.00	18,500
12/26/2023	Christopher Franklin Devall	COO	Buy	7,000	$2.55	$17,850.00	30,033
12/26/2023	Kyle Michael Wool	President	Buy	5,000	$2.60	$13,000.00	9,000
12/26/2023	Kyle Michael Wool	President	Buy	5,000	$2.60	$13,000.00	9,000
12/20/2023	Anthony Hayes	CEO	Buy	70,000	$2.00	$140,000.00	98,804
11/28/2023	Christopher Franklin Devall	COO	Buy	1,000	$2.26	$2,260.00	22,033
11/24/2023	Anthony Hayes	CEO	Buy	1,481	$2.16	$3,198.96	24,804
11/22/2023	Anthony Hayes	CEO	Buy	1,323	$2.09	$2,765.07	23,323
11/16/2023	Anthony Hayes	CEO	Buy	2,500	$1.97	$4,925.00	22,000
11/14/2023	Anthony Hayes	CEO	Buy	2,500	$1.93	$4,825.00	19,500
9/20/2023	Anthony Hayes	CEO	Buy	15,000	$2.59	$38,850.00	17,000
9/19/2023	Kyle Michael Wool	Director	Buy	2,000	$2.55	$5,100.00	6,000
9/13/2023	Anthony Hayes	CEO	Buy	2,000	$2.75	$5,500.00	2,000
9/11/2023	Kyle Michael Wool	Director	Buy	2,000	$2.82	$5,640.00	2,000
8/25/2023	Kyle Michael Wool	Director	Buy	2,000	$2.90	$5,800.00	818,858
8/23/2023	Anthony Hayes	CEO	Buy	2,000	$2.86	$5,720.00	218,506
8/21/2023	Kyle Michael Wool	Director	Buy	1,000	$2.99	$2,990.00	816,858
8/18/2023	Kyle Michael Wool	Director	Buy	1,369	$2.95	$4,038.55	815,858
8/16/2023	Anthony Hayes	CEO	Buy	2,000	$2.94	$5,880.00	216,506
8/14/2023	Kyle Michael Wool	Director	Buy	2,000	$3.00	$6,000.00	814,489
6/13/2023	Anthony Hayes	CEO	Buy	506	$2.89	$1,462.34	213,187
6/8/2023	Kyle Michael Wool	Director	Buy	424	$2.59	$1,098.16	281,274
5/30/2023	Kyle Michael Wool	Director	Buy	2,000	$2.59	$5,180.00	280,850
5/24/2023	Anthony Hayes	CEO	Buy	2,000	$2.75	$5,500.00	212,681
5/18/2023	Christopher Franklin Devall	COO	Buy	1,500	$2.94	$4,410.00	21,033
5/18/2023	Kyle Michael Wool	Director	Buy	2,000	$2.94	$5,880.00	278,792
5/16/2023	Anthony Hayes	CEO	Buy	2,000	$2.77	$5,540.00	208,681
4/5/2023	Christopher Franklin Devall	COO	Buy	5,698	$3.51	$19,999.98	19,533
4/4/2023	Anthony Hayes	CEO	Buy	30,000	$3.44	$103,200.00	206,681

Why Buffett, Bezos, & Congress Are Piling Into This One Sector

From InvestorPlace | Ad

Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…

Click here for the details

SEC Filings (Institutional Ownership Changes) for Dominari (NASDAQ:DOMH)

42.48% of Dominari stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Today's Range

Now: $1.71

$1.71

$1.78

50 Day Range

MA: $1.80

$1.56

$2.08

52 Week Range

Now: $1.71

$1.50

$3.20

Volume

2,113 shs

Average Volume

10,491 shs

Market Capitalization

$10.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Dominari?: Dominari's top insider investors include:
Kyle Michael Wool (Director)
Anthony Hayes (CEO)
Christopher Franklin Devall (COO)
Kyle Michael Wool (President)
Learn More about top insider investors at Dominari.